Literature DB >> 25465604

Thyroid volume in patients with glucose metabolism disorders.

Ayse Ocak Duran1, Cuneyd Anil2, Alptekin Gursoy3, Aslı Nar2, Mevlude Inanc1, Oktay Bozkurt1, Neslihan Bascil Tutuncu2.   

Abstract

OBJECTIVE: Thyroid volume and the prevalence of thyroid nodules are higher in patients with insulin resistance. A relationship between thyroid volume and glucose metabolism disorders (GMD) has not as yet been clarified. The present retrospective study aimed to investigate the association between GMD and thyroid volume. SUBJECTS AND METHODS: We investigated the data of 2,630 patients who were evaluated for thyroid biopsy in our hospital. The study population included 602 patients with GMD, 554 patients with diabetes mellitus (DM) and 1,474 patients with normal glucose metabolism as a control group. We obtained the levels of serum thyroid stimulating hormone (TSH) and the thyroid volumes of those patients retrospectively.
RESULTS: The median ages for the control group, GMD group and DM group were 55 (15-91) years, 60 (27-97) years, and 65 (27-91) years respectively and there was a statistically significant difference between the groups with regard to age and gender (p<0.001). Levels of TSH were similar in all groups. The median total thyroid volumes for patients with DM and GMD were significantly higher than that of the control group [22.5 (3-202) mL, 20.2 (4-190) mL, and 19.2 (3-168) mL respectively, p≤0.001 for all parameters]. Also the median total thyroid volume for patients with DM was significantly higher than that of the GMD group (p<0.001). According to the correlation analysis, thyroid volume was significantly correlated with age (r=0.92, p<0.001) and TSH (r=0.435, p<0.001). Age, gender, TSH levels, GMD and DM diagnosis were independently correlated with thyroid volume.
CONCLUSION: The thyroid gland is one of the target tissues of metabolic disorders. We reported a positive correlation between GMD/type 2 DM and thyroid volume. Further controlled, prospective, randomized studies on this subject are required to gain more information.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25465604     DOI: 10.1590/0004-2730000003418

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  11 in total

Review 1.  The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.

Authors:  Shilpa Thakur; Brianna Daley; Joanna Klubo-Gwiezdzinska
Journal:  J Mol Endocrinol       Date:  2019-08       Impact factor: 5.098

2.  Association between lifestyle and anthropometric parameters and thyroid nodule features.

Authors:  Grigorios Panagiotou; Despina Komninou; Panagiotis Anagnostis; George Linardos; Eleni Karoglou; Maria Somali; Leonidas Duntas; Marina Kita; Konstantinos Tziomalos; Kalliopi Pazaitou-Panayiotou
Journal:  Endocrine       Date:  2017-04-08       Impact factor: 3.633

Review 3.  Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.

Authors:  Ilgin Yildirim Simsir; Sevki Cetinkalp; Taylan Kabalak
Journal:  Med Princ Pract       Date:  2019-09-23       Impact factor: 1.927

4.  Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China.

Authors:  Weiping Tu; Gengsheng Zhang; Shuifen Yu; Jimei Tang; Jiangsu Yu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.

Authors:  Yasemin Aydoğan; Mustafa Altay; Oktay Ünsal; Veysel Kaplanoğlu; Yavuz Çağır; Canan Yıldız; Esin Beyan; Selma Uysal Ramadan
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

Review 6.  Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Authors:  Roberta Malaguarnera; Veronica Vella; Maria Luisa Nicolosi; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

7.  Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study.

Authors:  Xiaoying Ding; Ying Xu; Yufan Wang; Xiaohua Li; Chunhua Lu; Jing Su; Yuting Chen; Yuhang Ma; Yanhua Yin; Yong Wu; Yaqiong Jin; Lihua Yu; Junyi Jiang; Naisi Zhao; Qingwu Yan; Andrew S Greenberg; Haiyan Sun; Mingyu Gu; Li Zhao; Yunhong Huang; Yijie Wu; Chunxian Qian; Yongde Peng
Journal:  Mediators Inflamm       Date:  2017-05-21       Impact factor: 4.711

8.  Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects.

Authors:  Dalia Dauksiene; Janina Petkeviciene; Jurate Klumbiene; Rasa Verkauskiene; Jelena Vainikonyte-Kristapone; Audrone Seibokaite; Jonas Ceponis; Vygantas Sidlauskas; Laura Daugintyte-Petrusiene; Antanas Norkus; Birute Zilaitiene
Journal:  Int J Endocrinol       Date:  2017-03-05       Impact factor: 3.257

9.  The Relationship and Gender Disparity Between Thyroid Nodules and Metabolic Syndrome Components Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis.

Authors:  Fan Zhang; Yongze Li; Xiaohui Yu; Xichang Wang; Zheyu Lin; Bo Song; Lijun Tian; Chuyao Feng; Zhongyan Shan; Weiping Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-21       Impact factor: 5.555

10.  Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications.

Authors:  Renan Magalhães Montenegro Junior; Grayce Ellen da Cruz Paiva Lima; Virgínia Oliveira Fernandes; Ana Paula Dias Rangel Montenegro; Clarisse Mourão Melo Ponte; Lívia Vasconcelos Martins; Daniel Pascoalino Pinheiro; Maria Elisabete Amaral de Moraes; Manoel Odorico de Moraes Filho; Catarina Brasil d'Alva
Journal:  Diabetol Metab Syndr       Date:  2020-04-06       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.